Groundbreaking research exposes how ethnic minorities and low-income residents in Washington state faced significant barriers accessing life-saving COVID-19 vaccines from Moderna and Pfizer during the pandemic's critical early phases.
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
The US FDA has authorised updated COVID-19 vaccines from Pfizer and Moderna for emergency use. Major pharmacies like CVS and Walgreens are preparing to roll out the new shots targeting recent variants.
A new report reveals a surge in UK employees seeking a four-day workweek, with major firms like Moderna and Pfizer adopting the model to boost productivity and attract top talent.
The Biden administration has purchased 100 million doses of Moderna's newly updated COVID-19 vaccine, targeting the latest variants ahead of the autumn vaccination campaign.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?